 |
 |
 |
 |
 |
 |
Prostate cancer treatment options depend on several factors, including the stage and aggressiveness of the cancer, the patient’s overall health and preferences, and the expertise of healthcare providers. Treatment may involve a combination of approaches, including active surveillance, surgery, radiation therapy, hormone therapy, chemotherapy, immunotherapy, and other targeted therapies. Here are some common treatment options for prostate cancer:
- Active surveillance: Active surveillance, also known as watchful waiting, may be recommended for men with low-risk or early-stage prostate cancer that is slow-growing and unlikely to cause symptoms or harm during their lifetime. During active surveillance, regular monitoring with prostate-specific antigen (PSA) tests, digital rectal examinations (DRE), and occasional prostate biopsies is performed to assess disease progression and determine if treatment is necessary.
- Surgery: Surgical removal of the prostate gland, known as radical prostatectomy, may be recommended for men with localized or locally advanced prostate cancer. During a radical prostatectomy, the entire prostate gland, along with surrounding tissues, is removed. Depending on the extent of the cancer, nearby lymph nodes may also be removed. Common surgical techniques include open surgery, laparoscopic surgery, and robot-assisted laparoscopic surgery (robotic prostatectomy).
- Radiation therapy: Radiation therapy uses high-energy rays or particles to kill cancer cells and shrink tumors. It may be used as a primary treatment for localized or locally advanced prostate cancer or as adjuvant therapy after surgery to destroy any remaining cancer cells. External beam radiation therapy and brachytherapy (internal radiation therapy) are the two main types of radiation therapy used for prostate cancer.
- Hormone therapy: Hormone therapy, also known as androgen deprivation therapy (ADT), works by reducing the levels of androgens (male hormones) in the body, which can slow the growth and spread of prostate cancer cells. Hormone therapy may be used alone or in combination with other treatments, such as radiation therapy or chemotherapy, for advanced or metastatic prostate cancer.
- Chemotherapy: Chemotherapy uses drugs to kill cancer cells or stop them from growing and dividing. Chemotherapy may be used as a treatment option for advanced or metastatic prostate cancer that has spread to other parts of the body, particularly when hormone therapy is no longer effective.
- Immunotherapy: Immunotherapy works by stimulating the body’s immune system to recognize and attack cancer cells. Immunotherapy drugs, such as sipuleucel-T (Provenge) and pembrolizumab (Keytruda), may be used as treatment options for advanced or metastatic prostate cancer that has not responded to other treatments.
- Targeted therapy: Targeted therapy drugs work by targeting specific molecules or pathways involved in the growth and spread of cancer cells. Targeted therapy may be used as a treatment option for advanced or metastatic prostate cancer in certain cases, particularly when other treatments have not been effective.
- Palliative care: Palliative care focuses on providing relief from symptoms and improving the quality of life for patients with advanced or metastatic prostate cancer. Palliative care may include medications to control pain and other symptoms, as well as supportive care services such as nutrition counseling, physical therapy, and psychological support.
The choice of treatment for prostate cancer depends on individual factors such as the stage and aggressiveness of the cancer, overall health and preferences, and the expertise of healthcare providers. It’s important for patients to discuss their treatment options with their healthcare providers and to be actively involved in decisions about their care.